Novartis AG Acquires Costim Pharmaceuticals for Undisclosed Sum

  • Feed Type
  • Date
    2/17/2014
  • Company Name
    Costim Pharmaceuticals
  • Mailing Address
    200 Clarendon Street 54th Floor Boston, MA 02116
  • Company Description
    The company is developing a focused and highly attractive pipeline of antibody agents directed to costimulatory targets for the treatment of cancer.
  • Website
    http://www.costim.com
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Financial terms of the deal were not disclosed.

Trending on Xconomy